CVRx Garners $29,600,000 New Financing Round

  • Feed Type
  • Date
  • Company Name
  • Mailing Address
    9201 West Broadway Avenue Minneapolis, MN 55445
  • Company Description
    The company has developed proprietary technology for the treatment of high blood pressure, also referred to as hypertension, that cannot be controlled with medications (refractory or resistant hypertension).
  • Website
  • Transaction Type
    Venture Equity
  • Transaction Amount
  • Transaction Round
  • Proceeds Purposes
    CVRx plans to use the funding for the primary purposes of advancing its clinical trials and expanding its international commercial activities.
  • M&A Terms
  • Venture Investor
    New Enterprise Associates
  • Venture Investor
    Johnson & Johnson Development Corporation
  • Venture Investor
    BBT Fund
  • Venture Investor
    SightLine Partners

Trending on Xconomy